series-b
Stage
2
Investors
About
NUCLIDIUM develops a new generation of radiopharmaceuticals for the diagnosis and therapy of cancer. Their technology aims to improve patient outcomes through targeted treatments.
Explore NUCLIDIUM's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.